ArticleCancer research2022

A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor Progression.

Hui Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.